Maverick Therapeutics

📍 Brisbane, United States👥 3 employees💰 Last funded Mar 2019
Biotechnology Research🌐 mavericktx.com
Website LinkedIn
Maverick Therapeutics is now part of Takeda. Follow us at https://www.linkedin.com/company/takeda-pharmaceuticals/ Maverick Therapeutics is pioneering the next generation of redirected T-cell targeted immunotherapies. Maverick’s highly innovative platform, COBRA™, is the most advanced bispecific T-cell engaging platform in its class, designed to safely target solid tumors with highly specific and potent activity.
3
Total investors
1
Early stage
2
Mid stage
0
Late stage
—
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2016–2019 · investors recorded per year
2016120192
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Maverick Therapeutics?
Maverick Therapeutics has 3 investors on record on gritt.io, including 1 early-stage backers, 2 mid-stage.
When did Maverick Therapeutics last raise funding?
The most recent investment in Maverick Therapeutics recorded on gritt.io was in March 2019.
What industry is Maverick Therapeutics in?
Maverick Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Maverick Therapeutics based?
Maverick Therapeutics is headquartered in Brisbane, United States.